Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:
“ASCO 2026 LCSM Poster Session.
ctDNA Dynamics Following Molecularly Targeted Therapy for NSCLC.
Presented by Justin Jee.”
Other articles featuring Dr. Horinouchi on OncoDaily.